Walnut Lipid Markers Randomized Trial Evidence Table

Structured evidence table for Walnut Lipid Markers Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Walnut Lipid Markers Randomized TrialThe liver is particularly affected by HFD causing metabolic dysfunction associated with fatty liver disease.4Ali G (2024)Walnut extract protects against hepatic inflammation and toxicity induced by a high-fat diet.
Walnut Lipid Markers Randomized TrialSerum lipid profile; liver histology; hepatic antioxidants such as catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), lipid peroxidation (TBARS), and reduced glutathione (GSH); inflammatory markers like IL-6 and TNF-α; and phospholipids were determined.4Ali G (2024)Walnut extract protects against hepatic inflammation and toxicity induced by a high-fat diet.
Walnut Lipid Markers Randomized TrialThe HFD group showed increased hepatic fat accumulation as evidenced by biochemical and histopathological examinations compared to the control animals.4Ali G (2024)Walnut extract protects against hepatic inflammation and toxicity induced by a high-fat diet.
Walnut Lipid Markers Randomized TrialA high-fat diet (HFD) is one of the main causes of obesity and metabolic diseases.4Ali G (2024)Walnut extract protects against hepatic inflammation and toxicity induced by a high-fat diet.
Walnut Lipid Markers Randomized TrialPalm oil-based diet also boosted inflammatory aortic storm (increased expression of chemokines, cytokines, inflammasome components, and M1 macrophage phenotype markers) and promoted defective efferocytosis.4Lázaro I (2023)Walnut inclusion in a palm oil-based atherogenic diet promotes traits predicting stable atheroma plaque in <i>Apoe</i>-deficient mice.
Walnut Lipid Markers Randomized TrialConclusion The isocaloric inclusion of walnuts in an unhealthy high-fat diet promotes traits predicting stable advanced atheroma plaque in mid-life mice.4Lázaro I (2023)Walnut inclusion in a palm oil-based atherogenic diet promotes traits predicting stable atheroma plaque in <i>Apoe</i>-deficient mice.
Walnut Lipid Markers Randomized TrialThis contributes novel evidence for the benefits of walnuts, even in an unhealthy dietary environment.4Lázaro I (2023)Walnut inclusion in a palm oil-based atherogenic diet promotes traits predicting stable atheroma plaque in <i>Apoe</i>-deficient mice.
Walnut Lipid Markers Randomized TrialIntroduction The lower rates of cardiovascular disease in Southern Europe could be partially explained by the low prevalence of lipid-rich atheroma plaques.4Lázaro I (2023)Walnut inclusion in a palm oil-based atherogenic diet promotes traits predicting stable atheroma plaque in <i>Apoe</i>-deficient mice.
topicWalnut Lipid Markers Randomized Trial
claimThe liver is particularly affected by HFD causing metabolic dysfunction associated with fatty liver disease.
evidence level4
citationAli G (2024)
sourceWalnut extract protects against hepatic inflammation and toxicity induced by a high-fat diet.
topicWalnut Lipid Markers Randomized Trial
claimSerum lipid profile; liver histology; hepatic antioxidants such as catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), lipid peroxidation (TBARS), and reduced glutathione (GSH); inflammatory markers like IL-6 and TNF-α; and phospholipids were determined.
evidence level4
citationAli G (2024)
sourceWalnut extract protects against hepatic inflammation and toxicity induced by a high-fat diet.
topicWalnut Lipid Markers Randomized Trial
claimThe HFD group showed increased hepatic fat accumulation as evidenced by biochemical and histopathological examinations compared to the control animals.
evidence level4
citationAli G (2024)
sourceWalnut extract protects against hepatic inflammation and toxicity induced by a high-fat diet.
topicWalnut Lipid Markers Randomized Trial
claimA high-fat diet (HFD) is one of the main causes of obesity and metabolic diseases.
evidence level4
citationAli G (2024)
sourceWalnut extract protects against hepatic inflammation and toxicity induced by a high-fat diet.
topicWalnut Lipid Markers Randomized Trial
claimPalm oil-based diet also boosted inflammatory aortic storm (increased expression of chemokines, cytokines, inflammasome components, and M1 macrophage phenotype markers) and promoted defective efferocytosis.
evidence level4
citationLázaro I (2023)
sourceWalnut inclusion in a palm oil-based atherogenic diet promotes traits predicting stable atheroma plaque in <i>Apoe</i>-deficient mice.
topicWalnut Lipid Markers Randomized Trial
claimConclusion The isocaloric inclusion of walnuts in an unhealthy high-fat diet promotes traits predicting stable advanced atheroma plaque in mid-life mice.
evidence level4
citationLázaro I (2023)
sourceWalnut inclusion in a palm oil-based atherogenic diet promotes traits predicting stable atheroma plaque in <i>Apoe</i>-deficient mice.
topicWalnut Lipid Markers Randomized Trial
claimThis contributes novel evidence for the benefits of walnuts, even in an unhealthy dietary environment.
evidence level4
citationLázaro I (2023)
sourceWalnut inclusion in a palm oil-based atherogenic diet promotes traits predicting stable atheroma plaque in <i>Apoe</i>-deficient mice.
topicWalnut Lipid Markers Randomized Trial
claimIntroduction The lower rates of cardiovascular disease in Southern Europe could be partially explained by the low prevalence of lipid-rich atheroma plaques.
evidence level4
citationLázaro I (2023)
sourceWalnut inclusion in a palm oil-based atherogenic diet promotes traits predicting stable atheroma plaque in <i>Apoe</i>-deficient mice.

Source documents

  1. Walnut extract protects against hepatic inflammation and toxicity induced by a high-fat diet.
  2. Walnut inclusion in a palm oil-based atherogenic diet promotes traits predicting stable atheroma plaque in <i>Apoe</i>-deficient mice.